Risk of Ischemic and Hemorrhagic Stroke in Individuals With Type 1 and Type 2 Diabetes: A Nationwide Cohort Study in Sweden

被引:0
|
作者
Mavridis, Anastasios [1 ]
Viktorisson, Adam [1 ,2 ]
Eliasson, Bjorn [2 ,3 ]
von Euler, Mia [4 ]
Sunnerhagen, Katharina S. [1 ,2 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Gothenburg, Sweden
[3] Natl Diabet Register, Ctr Registers, Gothenburg, Sweden
[4] Orebro Univ, Fac Med & Hlth, Dept Neurol & Rehabil, Orebro, Sweden
关键词
MORTALITY; DISEASE;
D O I
10.1212/WNL.0000000000213480
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives Diabetes significantly increases the risk of cardiovascular events, including stroke. Although the association with ischemic stroke is well established, the relationship with hemorrhagic stroke remains unclear. This study aimed to evaluate the risk of ischemic and hemorrhagic stroke in individuals with type 1 and type 2 diabetes compared with diabetes-free controls from the general population. Methods This cohort study included individuals with type 1 or type 2 diabetes from the Swedish National Diabetes Register between 2005 and 2019, matched to diabetes-free controls by age and sex. Data on baseline characteristics, comorbidities, medications, and outcomes were collected from multiple national registers. Stroke incidence rates and adjusted hazard ratios were estimated using Cox proportional hazard models, stratified by diabetes type, for ischemic and hemorrhagic stroke. Results The study included 47,720 individuals with type 1 diabetes (mean age 34.4, 44.8% female) and 686,158 with type 2 diabetes (mean age 65.3, 43.3% female), matched to 143,160 and 2,058,474 controls, respectively. In individuals with type 1 diabetes, the ischemic stroke risk was 2.54 times higher (95% CI 2.36-2.73) and the hemorrhagic stroke risk was 1.88 times higher (95% CI 1.57-2.26) compared with controls. In individuals with type 2 diabetes, the ischemic stroke risk was 1.37 times higher (95% CI 1.35-1.38) while the hemorrhagic stroke risk was not significantly increased (HR: 0.99, 95% CI 0.96-1.02). Higher HbA1c levels were associated with increased ischemic stroke risk for both diabetes types. For hemorrhagic stroke, individuals with type 1 diabetes had significantly higher risk starting at HbA1c > 52 mmol/mol while in those with type 2 diabetes, a modest risk increase was observed only at HbA1c > 72 mmol/mol. Discussion The risk of ischemic stroke was higher for both diabetes types. Individuals with type 1 diabetes also exhibited a higher risk of hemorrhagic stroke compared with diabetes-free controls while type 2 diabetes was significantly associated with risk of hemorrhagic stroke only when HbA1c was higher than 72 mmol/mol. These findings highlight the increased stroke risk in diabetes, with distinct patterns by stroke subtype and diabetes type. Tailored prevention strategies are essential to address these differences.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Insulin resistance and risk of first stroke in type 2 diabetes: a nationwide cohort study
    Zabala, A.
    Darsalia, V.
    Lind, M.
    Svensson, A. -M.
    Franzen, S.
    Eliasson, B.
    Patrone, C.
    Jonsson, M.
    Nystrom, T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 4 - 4
  • [2] Cardiovascular risk of sitagliptin in ischemic stroke patients with type 2 diabetes and chronic kidney disease A nationwide cohort study
    Liang, Chung-Yu
    Chen, Dong-Yi
    Mao, Chun-Tai
    Hsieh, I-Chang
    Hung, Ming-Jui
    Wang, Chao-Hung
    Wen, Ming-Shien
    Cherng, Wen-Jin
    Chen, Tien-Hsing
    MEDICINE, 2018, 97 (52)
  • [3] The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes
    Hagg-Holmberg, Stefanie
    Dahlstrom, Emma H.
    Forsblom, Carol M.
    Harjutsalo, Valma
    Liebkind, Ron
    Putaala, Jukka
    Tatlisumak, Turgut
    Groop, Per-Henrik
    Thorn, Lena M.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [4] The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes
    Stefanie Hägg-Holmberg
    Emma H. Dahlström
    Carol M. Forsblom
    Valma Harjutsalo
    Ron Liebkind
    Jukka Putaala
    Turgut Tatlisumak
    Per-Henrik Groop
    Lena M. Thorn
    Cardiovascular Diabetology, 18
  • [5] Type 2 diabetes mellitus in patients with ischemic stroke - A nationwide study
    Hastrup, Sidsel
    Hedegaard, Jakob Nebeling
    Andersen, Grethe
    Rungby, Jorgen
    Johnsen, Soren Paaske
    DIABETIC MEDICINE, 2024, 41 (08)
  • [6] Different Risk Factor Profiles for Ischemic and Hemorrhagic Stroke in Type 1 Diabetes Mellitus
    Hagg, Stefanie
    Thorn, Lena M.
    Forsblom, Carol M.
    Gordin, Daniel
    Saraheimo, Markku
    Tolonen, Nina
    Waden, Johan
    Liebkind, Ron
    Putaala, Jukka
    Tatlisumak, Turgut
    Groop, Per-Henrik
    STROKE, 2014, 45 (09) : 2558 - +
  • [7] Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study
    Rawshani, Aidin
    Kjolhede, Elin Allansson
    Rawshani, Araz
    Sattar, Naveed
    Eeg-Olofsson, Katarina
    Adiels, Martin
    Ludvigsson, Johnny
    Lindh, Marcus
    Gisslen, Magnus
    Hagberg, Eva
    Lappas, Georgios
    Eliasson, Bjorn
    Rosengren, Annika
    LANCET REGIONAL HEALTH-EUROPE, 2021, 4
  • [8] Age at Menopause and Risk of Type 2 Diabetes: A Nationwide Cohort Study
    Nam, Ga Eun
    OBESITY, 2024, 32 : 145 - 145
  • [9] Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study
    Alexander Zabala
    Vladimer Darsalia
    Marcus Lind
    Ann-Marie Svensson
    Stefan Franzén
    Björn Eliasson
    Cesare Patrone
    Magnus Jonsson
    Thomas Nyström
    Cardiovascular Diabetology, 20
  • [10] Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study
    Zabala, Alexander
    Darsalia, Vladimer
    Lind, Marcus
    Svensson, Ann-Marie
    Franzen, Stefan
    Eliasson, Bjorn
    Patrone, Cesare
    Jonsson, Magnus
    Nystrom, Thomas
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)